Company intelligence / Profile preview

Bridges Israel

Glil Yam, Israel

Ownership: Private
Development stage: Other

Overview

Bridges Israel is an Israel-based impact investment fund, not a drug development biotech or pharmaceutical operating company. The firm invests in Israeli businesses with the goal of generating competitive financial returns alongside measurable social and environmental impact. Its investment strategies include Impact Growth and Impact Tech, and its portfolio spans sectors such as healthcare, climate and environmental services, education, advanced manufacturing, and related impact-oriented areas. Bridges Israel is an independent affiliate of Bridges Fund Management and appears to be an active private investment organization rather than a healthcare product developer.

Industry: Investors

Partnerships

Bridges Fund Management

Beyond the preview

Go deeper on Bridges Israel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bridges Israel.

Explore the full profile